Benzinga's Top #PreMarket Losers

By: via Benzinga
Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) shares declined 55.593% to $3.86 in pre-market trading on failure to reach goal in OHR-102 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.